Targeted Gene Evolution in Escherichia Coli Using a Highly Error-prone DNA Polymerase I
Overview
Affiliations
We present a system for random mutagenesis in Escherichia coli for the evolution of targeted genes. To increase error rates of DNA polymerase I (Pol I) replication, we introduced point mutations in three structural domains that govern Pol I fidelity. Expression of error-prone Pol I in vivo results in strong mutagenesis of a target sequence encoded in a Pol I-dependent plasmid (8.1 x 10-4 mutations per bp, an 80,000-fold increase), with a preference for plasmid relative to chromosome sequence. Mutagenesis is maximal in cultures maintained at stationary phase. Mutations are evenly distributed and show a variety of base pair substitutions, predominantly transitions. Mutagenesis extends at least 3 kb beyond the 400-500 nt reportedly synthesized by Pol I. We demonstrate that our error-prone Pol I can be used to generate enzymes with distinct properties by generating TEM-1 beta-lactamase mutants able to hydrolyze a third-generation lactam antibiotic, aztreonam. Three different mutations contribute to aztreonam resistance. Two are found in the extended-spectrum beta-lactamases most frequently identified in clinical isolates, and the third (G276R) has not been previously described. Our system of targeted mutagenesis in E. coli should have an impact on enzyme-based applications in areas such as synthetic chemistry, gene therapy, and molecular biology. Given the structural conservation between polymerases, this work should also provide a reference for altering the fidelity of other polymerases.
Harnessing microbial heterogeneity for improved biosynthesis fueled by synthetic biology.
Cao Y, Li J, Liu L, Du G, Liu Y Synth Syst Biotechnol. 2024; 10(1):281-293.
PMID: 39686977 PMC: 11646789. DOI: 10.1016/j.synbio.2024.11.004.
Ribeiro R, Moreira J, Goncalves J Sci Rep. 2024; 14(1):10608.
PMID: 38719911 PMC: 11079059. DOI: 10.1038/s41598-024-61230-z.
Ultrahigh-throughput screening-assisted in vivo directed evolution for enzyme engineering.
Chen S, Yang Z, Zhong Z, Yu S, Zhou J, Li J Biotechnol Biofuels Bioprod. 2024; 17(1):9.
PMID: 38254175 PMC: 10804518. DOI: 10.1186/s13068-024-02457-w.
Evolution and synthetic biology.
Ornelas M, Cournoyer J, Bram S, Mehta A Curr Opin Microbiol. 2023; 76:102394.
PMID: 37801925 PMC: 10842511. DOI: 10.1016/j.mib.2023.102394.
In vivo hypermutation and continuous evolution.
Molina R, Rix G, Mengiste A, Alvarez B, Seo D, Chen H Nat Rev Methods Primers. 2023; 2.
PMID: 37073402 PMC: 10108624. DOI: 10.1038/s43586-022-00130-w.